Retatrutide, an experimental drug by Eli Lilly, shows promising results in weight loss by targeting three hormones, ...
A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.
The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. With ...
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
We meet some of the first NHS patients, as expert says funding everyone eligible would "bankrupt" the service.
Eli Lilly cut its 2024 revenue guidance, saying demand for its obesity and diabetes drugs had not met its lofty expectations.
There’s still scope for a new generation of drugs to replace weight-loss market leaders like Novo Nordisk A/S’s Wegovy, ...